Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target
Yu‐Hung Wang,Chien‐Chin Lin,Kristian Gurashi,Bettina Wingelhofer,Fabio M. R. Amaral,Chi‐Yuan Yao,Hsin Ting Hsieh,Ming Chih Liu,Hsin‐An Hou,Wen‐Chien Chou,Kiran Batta,Daniel H. Wiseman,Hwei‐Fang Tien